Patents for A61K 49 - Preparations for testing in vivo (35,376)
09/1997
09/04/1997CA2247430A1 Use of labelled cck-b receptor ligands for the detection and localization of malignant human tumors
09/04/1997CA2217714A1 Method and prepackaged swabstick for epithelial cancer screening
09/03/1997EP0792931A2 Products and methods for controlling the suppression of the neoplastic phenotype
09/03/1997EP0792157A1 Preparation of mhc-peptide complexes
09/03/1997EP0792156A1 Methods for the prevention or treatment of vascular hemorrhaging and alzheimer's disease
09/03/1997EP0576521B1 Improvements in or relating to contrast agents
09/02/1997US5663482 Genetic engineering
09/02/1997US5663413 Biphenyl iodinated derivatives and their diagnostic use
09/02/1997US5663301 Metal ion-ligand coordination complexes, antibodies directed thereto, and assays using such antibodies
09/02/1997US5662885 Peptide derived radionuclide chelators
09/02/1997US5662883 Microprecipitation of micro-nanoparticulate pharmaceutical agents
09/02/1997CA1339415C Detection and treatment of infections with immunoconjugates
08/1997
08/28/1997WO1997031266A1 Process for determining the phototoxicity and/or photosensitivity of substances or mixtures thereof, and use thereof
08/28/1997WO1997031005A1 Polyazamacrocyclofluoromonoalkylphosphonic acids, and their complexes, for use as contrast agents
08/28/1997WO1997030969A1 Pharmaceutical agents containing perfluoroalkyl-containing metal complexes and the use thereof in tumour therapy and interventional radiology
08/28/1997WO1997030736A2 Contrast medium
08/28/1997WO1997030735A2 A process for the purification of opacifying contrast agents
08/28/1997WO1997030734A1 Magnetic resonance blood pool agents
08/28/1997WO1997030733A1 Magnetic resonance blood pool agents bound to human serum albumin
08/28/1997DE19608278A1 Pharmazeutische Mittel enthaltend perfluoralkylhaltige Metallkomplexe, und ihre Verwendung in der Tumortherapie und interventioniellen Radiologie Pharmaceutical preparations containing perfluoroalkyl-containing metal complexes, and their use in tumor therapy and radiology interventioniellen
08/28/1997DE19606207A1 Verfahren zur Bestimmung der Phototoxizität und/oder Photosensibilität von Stoffen oder Stoffgemischen sowie dessen Verwendung Method for determining the phototoxicity and / or photosensitivity of substances or mixtures of substances and its use
08/28/1997CA2247253A1 Pharmaceutical agents that contain perfluoroalkyl-containing metal complexes and their use in tumour therapy and interventional radiology
08/28/1997CA2247244A1 Magnetic resonance blood pool agents bound to human serum albumin
08/28/1997CA2247192A1 Process for determining the phototoxicity and/or photosensitivity of substances or mixtures thereof, and use thereof
08/28/1997CA2247041A1 Contrast medium
08/27/1997EP0791361A2 Method, apparatus, and medicine for clogging blood vessels of eye fundus
08/27/1997EP0791061A1 Animals with targeted gene disruption
08/27/1997EP0791056A2 Lipid-splitting enzyme
08/27/1997EP0702793A4 Anti-cd3 antibody-aminodextran conjugates for induction of t-cell activation and proliferation
08/27/1997EP0698119A4 Rapid diagnostic procedure for ivermectin resistance
08/27/1997EP0653063A4 In vitro test for dermal corrosive properties.
08/27/1997EP0563179B1 Vascular catheter having low-profile distal end
08/27/1997CN1158133A Peptide derived radionuclide chelators
08/27/1997CN1158082A Container with multi-phase composition for use in diagnostic and therapeutic applications
08/26/1997US5660827 Antibodies that bind to endoglin
08/26/1997US5660822 Polymers containing antifibrotic agents, compositions containing such polymers, and methods of preparation and use
08/26/1997US5660815 Water soluble fluorinated fatty acid sulfonate derivatives useful as magnetic resonance imaging agents
08/26/1997US5660814 Iodinated paramagnetic chelates, and their use as contrast agents
08/21/1997WO1997030174A1 Combinations of pkc inhibitors and therapeutic agents for treating cancers
08/21/1997WO1997030108A1 Characterized brca1 and brca2 proteins and screening and therapeutic methods based on characterized brca1 and brca2 proteins
08/21/1997WO1997029836A1 Apparatus and method for producing polarised vapour-phase helium-3, particularly for nmr imaging
08/21/1997WO1997029785A1 Diagnostic agent for digestive diseases
08/21/1997WO1997029783A1 Improvements in or relating to contrast agents
08/21/1997WO1997029782A1 Thermally stabilized contrast agent
08/21/1997DE19606223A1 Kit for epicutaneous tests for determination of allergens such as dental amalgam
08/21/1997CA2246778A1 Thermally stabilized contrast agent
08/21/1997CA2246734A1 Combinations of pkc inhibitors and therapeutic agents for treating cancers
08/21/1997CA2246665A1 Diagnostic agent for digestive diseases
08/20/1997EP0789783A1 Antigen binding peptides (abtides) from peptide libraries
08/20/1997EP0789594A1 Use of additives in contrast mediums to improve imaging
08/20/1997EP0593446B1 Monoclonal antibody which distinguishes helper inducer and supressor inducer cd4+ lymphocytes
08/20/1997CN1157573A Improvement in or relating to contrast agents
08/20/1997CN1035661C Low-density contrast medium
08/19/1997US5658962 Omega-hydrofluoroalkyl ethers, precursor carboxylic acids and derivatives thereof, and their preparation and application
08/19/1997US5658880 Prevent selectin binding; antiinflammatory, anticancer agents; aids therapy
08/19/1997US5658741 Anti-CD3 antibody-aminodextran conjugates for induction of T-cell activation and proliferation
08/19/1997US5658551 Stable microbubbles suspensions injectable into living organisms
08/19/1997US5658550 Non cross-linked synthetic polymers as contrast media for magnetic resonance imaging
08/19/1997CA1339340C Method for tumor detection and treatment
08/18/1997EP1011415A4 Non-invasive method for diagnosing alzheimer's disease in a patient
08/14/1997WO1997029128A1 GPIb-LIPID COMPLEX AND USES THEREOF
08/14/1997WO1997029114A1 Biotin-containing compounds, biotinylation reagents and methods
08/14/1997WO1997014679A3 Method of detecting cyclooxygenase-2
08/14/1997WO1997005904A3 Use of metal clusters as a contrast or radiotherapy agent
08/14/1997DE19604484A1 Operation fields in living beings are long term stained
08/13/1997EP0788376A2 Calixarene conjugates useful as mri and ct diagnostic imaging agents
08/13/1997EP0788374A2 Cell-specific gene delivery vehicles
08/13/1997EP0788364A1 Treatment of urogenital cancer with boron neutron capture therapy
08/13/1997EP0788348A1 Container with multi-phase composition for use in diagnostic and therapeutic applications
08/13/1997EP0689430B1 Superparamagnetic particles, process for producing the same and their use
08/13/1997EP0638064B1 Substituted 1,1,2-triphenylbutenes and their use in the treatment and diagnosis of cancer
08/13/1997EP0558663B1 Drug delivery porphyrin compositions and methods
08/13/1997EP0458937B1 Variants of pai-2
08/13/1997CN1156626A Dextran albumin acoustical contrast medium containing perfluocarbon and its producing process
08/12/1997US5656651 Androgenic directed compositions
08/12/1997US5656600 Modified polypeptides
08/12/1997US5656211 Apparatus and method for making gas-filled vesicles of optimal size
08/07/1997WO1997028262A1 Lyst1 and lyst2 gene compositions and methods of use
08/07/1997WO1997028250A1 Androgen-repressed metastatic human prostate cancer cell line
08/07/1997WO1997027888A1 Methods for embolizing blood vessels
08/07/1997WO1997027801A1 Laser opto-acoustic imaging system
08/07/1997WO1997027745A1 Method of diagnosis and treatment and related compositions and apparatus
08/07/1997WO1997004811A3 Use of liposomal preparations in indirect mri lymphography
08/07/1997DE19703816A1 Additives for injection or infusion solutions, especially of contrast agents
08/07/1997CA2244889A1 Androgen-repressed metastatic human prostate cancer cell line
08/06/1997EP0787797A1 Human 5-HT1D receptor (serotonin receptor), process for preparing the same, its uses, antibodies directed against this receptor and transgenics expressing it
08/06/1997EP0787017A1 Diagnostic preparation for detection of helicobacter pylori
08/06/1997EP0664819B1 Chelating polymers
08/06/1997EP0525181B1 Novel lanthanide chelate-conjugated oligonucleotides
08/06/1997CN1156442A Dimer DTPA derivatives and their metal complexes, pharmaceuticals containing the same, the use in diagnosis and therapy and process for preparing said complexes and pharmaceuticals
08/06/1997CN1035542C Method for preparing contrast media
08/05/1997US5654452 Lipophilic contrast agents for use in hepatocyte-selective oil-in-water emulsions
08/05/1997US5654413 Oligonucleotide tags for specific hybridization
08/05/1997US5654195 Vectors expressing hybrid viruses, methods of use and novel assays
08/05/1997US5654160 Imine- and mercaptan-containing aryl ligands; quantitative analysis; immunoassay; detecting metal concentrations in blood samples
08/05/1997US5653960 Tetra-aza macrocycles, processes for their preparation and their use in magnetic resonance imaging
08/05/1997US5653959 Compositions for increasing the image contrast in diagnostic investigations of the digestive tract of patients
08/05/1997US5653693 Obtained by molding propylene resin composition and phosphoric ester nucleating agent; syringe is prefilled with drug
08/05/1997CA1339204C Mucin core polypeptide, antibodies and probes
07/1997
07/31/1997WO1997027462A2 Use of peptides in tracing disease and developing vaccines